ResMed (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed (ASX: RMD)
Latest News
Healthcare Shares
Should you buy ResMed shares at their 52-week low?
Healthcare Shares
3 ASX healthcare shares to buy while they're on sale
Broker Notes
Top brokers name 3 ASX shares to buy next week
How to invest
Money to invest? I'd follow Warren Buffett to get rich
Growth Shares
3 of the best Aussie ASX growth shares to buy and hold until 2036
Healthcare Shares
3 reasons to buy this $42 billion ASX healthcare share
Growth Shares
3 high-quality ASX growth shares for smart investors to buy and hold for 10 years
Broker Notes
Buy, hold, sell: Coles, Liontown, and ResMed shares
Healthcare Shares
4 ASX healthcare shares to buy as sector struggles: experts
Blue Chip Shares
1 ASX blue chip stock I'd consider buying with the ASX 200 around 8,700
Broker Notes
Leading brokers name 3 ASX shares to buy today
Blue Chip Shares
3 ASX blue chip shares to buy with $10,000
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.